Related Experiment Video
Updated: Jul 26, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort
Bissene Douma1, Thouraya Ben Younes1,2, Hanene Benrhouma1,2
1Research Laboratory LR18SP04 and Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, Tunis, Tunisia.
Insights
Autoimmune encephalitis (AE) in children presents with seizures and behavioral issues. Early diagnosis and immunotherapy, including corticosteroids and immunoglobulin, lead to improvement in most pediatric AE cases.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Autoimmune Disorders
Background:
- Autoimmune encephalitis (AE) is a serious brain condition caused by the immune system attacking neurons.
- AE is increasingly diagnosed in pediatric populations.
- Recognizing AE is crucial for timely intervention.
Purpose of the Study:
- To detail the clinical, imaging, and lab findings in Tunisian children with AE.
- To analyze treatment strategies and outcomes for pediatric AE.
- To contribute to understanding AE in a specific geographic cohort.
Main Methods:
- Retrospective review of medical records for pediatric AE cases (2004-2020).
- Analysis of clinical presentations, neuroimaging (MRI), and laboratory data.
- Evaluation of therapeutic interventions and patient outcomes.
Main Results:
- Nineteen children (median age 7.68 years) were studied, with seizures and behavioral changes being common.
- Anti-NMDA receptor encephalitis was the most frequent type (11 cases).
- Eighteen patients improved with immunotherapy; one patient with anti-GAD encephalitis died.
Conclusions:
- Diagnosing AE in children can be difficult due to varied symptoms.
- Prompt and accurate diagnosis is vital for effective treatment of pediatric AE.
- First-line immunotherapy shows significant efficacy in most pediatric AE cases.
Background:
Autoimmune encephalitis (AE) is a rapidly progressive encephalopathy caused by antibodies targeting neurons in the central nervous system generating specific immune responses. It is increasingly recognized in children.
Objective:
To describe clinical, neuroimaging, and laboratory features, treatment, and outcome in a cohort of Tunisian children with AE.
Methods:
We conducted a retrospective review of the medical records of all children attending the Department of Child and Adolescent Neurology (Tunis) with autoimmune encephalitis between 2004 and 2020. Clinical, neuroimaging, laboratory features, therapeutic data, and outcome were analyzed.
Results:
Nineteen children were included in the study (12 girls and 7 boys). The median age at diagnosis was 7.68 years (range: 10 months-13 years). The most frequent manifestations were seizures and behavioral disorders. Eleven cases were diagnosed with anti-NMDA receptor encephalitis, 4 cases with anti-Ma2 encephalitis, 3 cases with anti-GAD encephalitis, and 1 case with anti-SOX1 encephalitis. Brain MRI showed increased T2 and fluid-attenuated inversion recovery (FLAIR) signal of the temporal lobe in 5 patients. Eighteen patients showed improvement following first-line immunotherapy (high-dose corticosteroids, intravenous immunoglobulin). One patient with anti-GAD encephalitis died despite escalating immunotherapy.
Conclusion:
Diagnosis of autoimmune encephalitis is challenging in children, because of misleading presentations. An early and accurate diagnosis is important to enable proper therapeutic interventions.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

